Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Pharmaceuticals & Biotech
/
Thermo Fisher Scientific
TMO
Thermo Fisher Scientific
The demand for personalized medicine will keep Thermo Fisher Scientific thriving
UN
Unike
Invested
Community Contributor
Published
10 Mar 25
Updated
18 Mar 25
21
Set Fair Value
0
votes
Share
Unike
's Fair Value
US$540.27
7.5% undervalued
intrinsic discount
18 Mar
US$499.99
Loading
1Y
-17.5%
7D
2.2%
Author's Valuation
US$540.3
7.5% undervalued
intrinsic discount
Unike's Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
Unike
's
Fair Value
US$540.3
7.5% undervalued
intrinsic discount
Future estimation in
5 Years
time period
Past
Future
0
60b
2014
2017
2020
2023
2025
2026
2029
2030
Revenue US$60.1b
Earnings US$9.6b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
4.73%
Life Sciences revenue growth rate
0.32%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.51%
Calculation
US$9.62b
Earnings '30
x
28.00x
PE Ratio '30
=
US$269.43b
Market Cap '30
US$269.43b
Market Cap '30
/
355.75m
No. shares '30
=
US$757.34
Share Price '30
US$757.34
Share Price '30
Discounted to 2025 @ 6.99% p.a.
=
US$540.27
Fair Value '25
